Our approach pairs personalized hormone therapy through expert EvexiPEL providers with targeted nutraceuticals to help patients look, feel, and live better, for longer
In its pivotal trial, 62% of patients treated with Saxenda lost at least 5% of their body weight compared with 34% of patients treated with placebo
A high-throughput and pathophysiologically relevant astrocyte-motor neuron co-culture assay for amyotrophic lateral sclerosis therapeutic discovery
This means temporarily pausing retinoids, vitamin C, and exfoliating acids
Whether you require a standard clinical titration or a precision microdosing schedule, our team manages your entire care plan from consultation to script delivery
Tracking should reassure rather than catastrophize Notes can be useful, but only if they help you see reality more clearly